CN102406102B - Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies - Google Patents
Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies Download PDFInfo
- Publication number
- CN102406102B CN102406102B CN2011103651138A CN201110365113A CN102406102B CN 102406102 B CN102406102 B CN 102406102B CN 2011103651138 A CN2011103651138 A CN 2011103651138A CN 201110365113 A CN201110365113 A CN 201110365113A CN 102406102 B CN102406102 B CN 102406102B
- Authority
- CN
- China
- Prior art keywords
- milk
- product
- baby
- carragheen
- stabilizing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 59
- 239000003381 stabilizer Substances 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 235000013336 milk Nutrition 0.000 title abstract description 55
- 239000008267 milk Substances 0.000 title abstract description 55
- 210000004080 milk Anatomy 0.000 title abstract description 55
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920000161 Locust bean gum Polymers 0.000 claims abstract description 15
- 239000000711 locust bean gum Substances 0.000 claims abstract description 15
- 235000010420 locust bean gum Nutrition 0.000 claims abstract description 15
- 229920002907 Guar gum Polymers 0.000 claims abstract description 14
- 239000000665 guar gum Substances 0.000 claims abstract description 14
- 235000010417 guar gum Nutrition 0.000 claims abstract description 14
- 229960002154 guar gum Drugs 0.000 claims abstract description 14
- 241000206575 Chondrus crispus Species 0.000 claims description 25
- 235000013350 formula milk Nutrition 0.000 description 33
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 26
- 235000020256 human milk Nutrition 0.000 description 19
- 210000004251 human milk Anatomy 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 17
- 235000021342 arachidonic acid Nutrition 0.000 description 13
- 229940114079 arachidonic acid Drugs 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 239000002245 particle Substances 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 102000004407 Lactalbumin Human genes 0.000 description 8
- 108090000942 Lactalbumin Proteins 0.000 description 8
- 235000013365 dairy product Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 230000036417 physical growth Effects 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 230000002596 correlated effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000020122 reconstituted milk Nutrition 0.000 description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 102000010445 Lactoferrin Human genes 0.000 description 3
- 108010063045 Lactoferrin Proteins 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 235000019483 Peanut oil Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 235000021242 lactoferrin Nutrition 0.000 description 3
- 229940078795 lactoferrin Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 239000000312 peanut oil Substances 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 238000012859 sterile filling Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- -1 sucrose ester Chemical class 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- WZYRMLAWNVOIEX-MOJAZDJTSA-N (2s)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetaldehyde Chemical compound O=C[C@@H](O)[C@@H]1OC[C@H](O)[C@H]1O WZYRMLAWNVOIEX-MOJAZDJTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 description 1
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DKHJWWRYTONYHB-UHFFFAOYSA-N CPP Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1 DKHJWWRYTONYHB-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-IGMARMGPSA-N Calcium-40 Chemical compound [40Ca] OYPRJOBELJOOCE-IGMARMGPSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000007058 Halophila ovalis Species 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical class C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000005293 duran Substances 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000010901 surplus milk Substances 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Landscapes
- Dairy Products (AREA)
Abstract
The invention relates to a stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies. The stabilizing agent composition comprises carragheenan, guar gum, locust bean gum and monoglyceride. The composition can be used as the stabilizing agent for liquid state milk for neonates to 6-month babies, and can enhance the stability of the product.
Description
Technical field
The invention belongs to milk product additive and milk product manufacture field, particularly, the present invention relates to a kind of stabiliser compositions and in nascent application to 6 months liquid condition milk for baby, and the liquid condition milk for baby of producing thus.
Background technology
Babies is significant in life period, breast milk is undoubtedly the optimal wholefood of baby, yet due to reasons such as working condition, occupation, diseases, the nursing present situation of breast milk is unsatisfactory, show according to interrelated data, the baby breastfeeding rate that China came into being six months: the city is about 20%, the rural area is about 60%, and on present China market, infant's milk powder substitute kind is limited, nutritional labeling is not comprehensive yet, and the infant formula of therefore producing reasonably, be fit to infant growth is extremely urgent.
Concerning the baby, best food is breast milk, because the composition that contains the necessary nutriment of infant physical growth in breast milk and strengthen infant immunity, but now in society, often cause for various reasons a lot of women breast-feeding their children to provide enough breast milks for the baby, we just have to seek a kind of method, obtain a kind of substitute that can replace in some sense breast milk.
Milk be up to now people from occurring in nature can obtain near perfect a kind of food, animal protein, butter oil and vitamin etc. that he not only can provide health and brain to grow needed high-quality to people, but also be the optimal selection of calcium replenishing.
But make a big difference on the composition of breast milk and milk, wherein for example aliphatic acid forms and breast milk makes a big difference, lack linoleic acid plus linolenic acid, also lack arachidonic acid (ARA) and DHA (DHA), there is a lot of baby milks to make every effort to accomplish approach with breast milk in prior art, people constantly exploring and effort, on composition and function, make the composition proportion of baby milk more and more near breast milk always for this reason.
Simultaneously, in existing society, people's rhythm of life than very fast, is that a loaded down with trivial details easily appearance is such as misplacing the problems such as ratio, pollution for cooling boiling water for baby rushes milk powder.So making every effort to obtain a kind of baby's liquid milk always, people substitute to a certain extent baby milk, but due to technical reason, cause albumen precipitation such as multiple foreign substance adds can influence each other in milk, fat floats in a large number, nutriment sex change etc. problem.
CN101427798A discloses a kind of liquid condition milk for baby, the stabilizing agent that proposes to use is selected from: phosphatide, carragheen, guar gum, locust bean gum, single/pair/triglyceride, monoglyceride, the combination of two or more in sucrose ester, wherein specifically used carragheen (0.01~0.05 % by weight), locust bean gum (0.02~0.08 % by weight), single/pair/combination of triglyceride (0.02~0.08 % by weight), perhaps guar gum (0.05~0.1 % by weight), single/pair/triglyceride (0.02~0.05 % by weight), the composition of monoglyceride (0.02~0.05 % by weight), perhaps phosphatide (0.05~0.1 % by weight), single/pair/triglyceride (0.02~0.05 % by weight), the combination of sucrose ester (0.05~0.1 % by weight).
CN101322522A discloses a kind of frozen, propose stabilizing agent and can be monoglyceride, sodium carboxymethylcellulose, carragheen, guar gum, xanthans, locust bean gum or its mixture, wherein specifically used the combination (0.2 % by weight) of monoglyceride and sodium carboxymethylcellulose, or the combination of monoglyceride and carragheen (0.2 % by weight), or sodium carboxymethylcellulose (0.2 % by weight), the combination of locust bean gum (0.03 % by weight) and carragheen (0.07 % by weight), or sodium carboxymethylcellulose, the combination of carragheen and guar gum (0.25 % by weight), or carragheen or locust bean gum (0.15 % by weight).
For the liquid condition milk for baby product of complicated component, the stabilizing agent in above-mentioned document is still not ideal enough, and the stability of product and holding time need further to improve.
Summary of the invention
The purpose of this invention is to provide a kind of stabiliser compositions and the application in the liquid lacteal product of baby's use in 6 months of coming into being thereof.Owing to containing stabiliser compositions of the present invention, the holding time of milk product and stability have obtained beyond thought improvement, can store at normal temperatures more than 6 months and have good stability.
The invention provides a kind of stabiliser compositions, said composition comprises carragheen, guar gum, locust bean gum and monoglyceride, wherein, the weight ratio of described carragheen, guar gum, locust bean gum, monoglyceride is 0.04~0.13: 0.2~1: 1~2: 0.5~1.5.
Carragheen is called again antler glue, carrageenan.Carragheen is the hydrophilic colloid that extract from some red algae sea grass, calcium, potassium, sodium, the ammonium salt of the polysaccharide sulfuric ester that its chemical constitution is comprised of galactolipin and Anhydrogalactose.Due to the difference of sulfuric ester combining form wherein, can be divided into A Ou tower (τ, Iota), card handkerchief type (κ, Kappa) and lambda type (λ, Lamda) etc.Carragheen can be used as adhesive, thickener, emulsifying agent and the stabilizing agent of food, medicine and cosmetics.
In stabiliser compositions of the present invention, described carragheen is preferably κ type carragheen.
Stabiliser compositions of the present invention is preferably as the liquid lacteal product of stabilizing agent for the production of the baby's use in 6 months of coming into being.
Preferably, described stabiliser compositions is that 0.04 ‰~0.13 ‰ amount of the gross weight take the amount of carragheen wherein as the described nascent liquid lacteal product that uses to 6 months babies is added in described liquid lacteal product.
The product that uses simultaneously the present invention to produce is the nutritional labeling according to infant and breast milk, take fresh milk (or reconstituted milk), WPC, vegetable oil, carbohydrate etc. as raw material, according to the breast milk composition ratio, the ratio that has increased lactalbumin, made casein and lactalbumin is is easily digested and assimilated by the baby near breast milk; Add compound sugar, improve intestinal environment; Add sugared carbohydrate supplementation; Add taurine, DHA, arachidonic acid, promote the feeding infant nervous system development; Add lactoferrin, nucleotides etc., infant immunity is engulfed, improved to the Promote immunity cell to external germ, thereby the effect that reaches the necessary nutriment of infant physical growth and strengthen infant immunity, the formula of the present invention's design makes baby's fluid milk stability more outstanding, nutritional labeling is more reasonable, the product that the present invention simultaneously produces is compared with fresh milk and ordinary powdered milk, have advantages of that instant, nutrition-allocated proportion science, local flavor are aromatic, the designed formula of the present invention is applicable to 0~6 month liquid condition milk for baby product and uses.
So produce and obtain being applicable to nascent liquid breast to 6 months babies; it is characterized in that: described liquid breast comprises cow's milk or reconstituted milk, WPC, sugar, vegetable oil, described stabiliser compositions, taurine, nucleotides, CPP, DHA, arachidonic acid, lactoferrin, galactooligosaccharide, FOS, B B-complex, composite trace element and water, wherein:
by weight, cow's milk or reconstituted milk account for 18.5%~33%, WPC accounts for 0.8%~1.6%, sugar accounts for 3.1%~8.5%, vegetable oil accounts for 0.35%~2.5%, described stabiliser compositions accounts for 0.01~0.6%, taurine accounts for 3~10mg/100g, nucleotides accounts for 1~7mg/100g, CPP accounts for 20~30mg/100g, DHA accounts for 0~0.5% of TFA, eicosatetraenoic acid accounts for 0~1% of TFA, lactoferrin accounts for 4~15mg/100g, galactooligosaccharide accounts for 50~70mg/100g, FOS accounts for 40~60mg/100g, choline accounts for 5~28mg/100g, B B-complex accounts for 0.007%~0.03%, composite trace element accounts for 0.00005%~0.08%, all the other are water,
The described liquid Ruzhong of every 100g, described B B-complex comprises: vitamin A 150~500IU, cholecalciferol 30~50IU, vitamin E 0.4~1.6IU, vitamin C 3~10mg, vitamin K 3~10 μ g, vitamin B2 30~120 μ g, vitamin B6 30~140 μ g, cobalamin 0.01~0.15 μ g, nicotinic acid 0.25~0.75mg, pantothenic acid 200~500 μ g, folic acid 4~15 μ g and biotin 1~3 μ g;
The described liquid Ruzhong of every 100g, described composite trace element comprises: calcium 40~90mg, phosphorus 20~70mg, magnesium 4~10mg, potassium 50~140mg, iron 0.5~1.6mg, zinc 0.3~1mg, sodium 10~50mg, iodine 4~40 μ g, copper 30~100 μ g, manganese 3.4~7.5 μ g.
Reconstituted milk described herein be with whole milk powder, skimmed milk power or rare cream water restore produce with dairy products like the liquid milk group categories.
Preferably, in described liquid Ruzhong, described vegetable oil is selected from: the combination of one or more in soybean oil, peanut oil, sunflower oil and corn oil.
More preferably, described vegetable oil is selected from peanut oil, soybean oil and corn oil, and part by weight is: peanut oil accounts for 0.05~0.2%, and soybean oil accounts for 0.2~0.7%, and corn oil accounts for 0.1~0.4%.
In addition, in described liquid Ruzhong, preferred described nucleotides consist of 5'-AMP salt, guanosine 5 '-phosphate, 5'-cytidylic acid salt, uridine 5 '-phosphate and inosine 5 '-phosphate.
In described liquid Ruzhong, preferably, in described composite trace element, iron is provided by one or more iron preparation combinations in grape acid ferrous iron, ferrous sulfate, ferrous lactate, ironic citrate and ferric pyrophosphate; Zinc is provided by one or more zinc preparation combinations in zinc sulfate, zinc gluconate, zinc lactate and zinc chloride; Calcium is provided by one or more calcium preparation combinations in milk calcium, calcium citrate, calcium phosphate, calcium chloride, calcium carbonate and calcium lactate; Magnesium is provided by one or more magnesium preparation combinations in magnesium sulfate, magnesium chloride and magnesium citrate; Iodine is provided by KI; Manganese is provided by manganese sulfate; Copper is provided by copper sulphate.
Arachidonic acid (ARA) and DHA (DHA) are the essential fatty acids of mankind's early development.Cerebral gray matter 22.1%, 23.9% being consisted of by phosphatide of white matter, retinal photoreceptor also contains abundant phosphatide, and the aliphatic acid that consists of phosphatide is mainly ARA and DHA.Take in the DHA ratio when too high in tissue the level of ARA descend, the minimizing of ARA is not only influential to the film function, and also influential to its 20 carbonizable substances (prostaglandin and thromboxane) that synthesize, thereby affects the perfect of the growth of organ and cell function; And when the ARA ratio is too high, can suppress again the synthetic of DHA.The balance that keeps ARA and DHA for infant's particular importance, is added separately DHA and may be caused the unbalance condition of formulated infant milk in baby milk, thereby causes that abnormal tissue fat acid consists of.
DHA can derive from algae or deep sea fish oil.In liquid condition milk for baby of the present invention, when adding DHA, add at least the arachidonic acid of DHA weight more than 1.05 times.
The preferred ratio of ARA and DHA is 1.8~2.3: 1.
The sugar that is used for liquid breast is selected from: one or more combinations of lactose, glucose, sucrose, dextrin and gelatinized starch.
Description of drawings
The particle size distribution figure of Fig. 1~Fig. 4 for utilizing laser diffraction granularity analyzer (MASTERSIZER 2000) that particle diameter in the liquid condition milk for baby milk of embodiment 1~embodiment 4 is analyzed;
Fig. 5 and Fig. 6 are the particle size distribution figure that in the liquid condition milk for baby milk of Comparative Examples 1 and 2, particle diameter is analyzed.
The specific embodiment
Liquid condition milk for baby of the present invention can adopt conventional dairy products production technology to produce.
in following examples, production technology used is conventional dairy products production technology, for example, technological process can be as follows: former milk check → milk collection (1 ℃~8 ℃) → storage → (85 ℃ ± 5 ℃/15s of clean breast (removing the mechanical admixture in former milk) → pasteurizes, be cooled to 1 ℃~8 ℃ after sterilization) → (will prepare burden milk and/or water are heated to 75 ℃ ± 5 ℃ to degreasing → batching, add stabilizing agent, the auxiliary materials such as sugar, employing has mixing, disperse, the material equipment of shear effect, make feed liquid become homogeneous mixture, and carry out homogeneous (homogenization pressure 150~250bar), then be cooled to below 10 ℃, add surplus milk, mixing and the constant volumes such as water) → UHTS (137 ℃~139 ℃/4S) → sterile filling (≤25 ℃).
The production of product of the present invention and detection all meet national standard (GB 10765-2010).Product of the present invention has carried out acute toxicity test, genetic toxicity test, had fed the animal experiments such as experiment, traditional teratogenicity test in 30 days, proves that this product safety is nontoxic, has simultaneously the effect that promotes mouse growth.
Embodiment
The liquid condition milk for baby formula of the present embodiment is (in one ton of product):
Wherein, stabilizing agent used is comprised of carragheen, guar gum, locust bean gum, monoglyceride, and weight ratio is 0.13: 0.2: 2: 0.5.Each material performance index used meets the correlated quality standard-required.
According to obtaining the liquid condition milk for baby product of the present embodiment after above-mentioned production technology production and can.Product after can dispatch from the factory after heat insulation experiment is qualified.
The liquid condition milk for baby product feature of the present embodiment is: fat content is about 3.1%, and protein content is about 2.3% (lactalbumin and caseic ratio are 3: 2), and the product viscosity is about 5.73~7.21 centipoises.No. 0 rotor of Brookfield LVDV-III type, 30rpm, 25 ℃ of room temperatures), the pH value is about 6.7.This product smooth mouth feel when drinking is smooth and easy, and local flavor is near breast milk and discharge good.
The liquid condition milk for baby formula of the present embodiment is (in one ton of product):
Wherein, stabilizing agent used is comprised of carragheen, guar gum, locust bean gum, monoglyceride, and weight ratio is 0.04: 1: 1: 1.5.Each material performance index used meets the correlated quality standard-required.Production technology used is above-mentioned conventional dairy products production technology.
The liquid condition milk for baby product feature of the present embodiment is: fat content is about 2.6%, protein content is about 2.2% (lactalbumin and caseic ratio are 3: 2), the product viscosity is about 5.73~7.21 centipoises (No. 0 rotor of Brookfield LVDV-III type, 30rpm, 25 ℃ of room temperatures), the pH value is about 6.7.This product smooth mouth feel when drinking is smooth and easy, and local flavor is near breast milk and discharge good.
The liquid condition milk for baby formula of the present embodiment is (in one ton of product):
Wherein, stabilizing agent used is comprised of carragheen, guar gum, locust bean gum, monoglyceride, and weight ratio is 0.07: 0.5: 1.2: 0.8.Each material performance index used meets the correlated quality standard-required.Production technology used is above-mentioned conventional dairy products production technology.
The liquid condition milk for baby product feature of the present embodiment is: fat content is about 2.1%, protein content is about 1.85% (lactalbumin and caseic ratio are 3: 2), the product viscosity is about 5.73~7.21 centipoises (No. 0 rotor of Brookfield LVDV-III type, 30rpm, 25 ℃ of room temperatures), the pH value is about 6.7.This product smooth mouth feel when drinking is smooth and easy, and local flavor is near breast milk and discharge good.
The liquid condition milk for baby formula of the present embodiment is (in one ton of product):
Wherein, stabilizing agent used is comprised of carragheen, guar gum, locust bean gum, monoglyceride, and weight ratio is 0.1: 0.7: 1: 1.Each material performance index used meets the correlated quality standard-required.Production technology used is conventional dairy products production technology.
The liquid condition milk for baby product feature of the present embodiment is: fat content is about 2.1%, protein content is about 1.4% (lactalbumin and caseic ratio are 3: 2), the product viscosity is about 5.73~7.21 centipoises (No. 0 rotor of Brookfield LVDV-III type, 30rpm, 25 ℃ of room temperatures), the pH value is about 6.7.This product smooth mouth feel when drinking is smooth and easy, and local flavor is near breast milk and discharge good.
Comparative Examples 1, (commercially available liquid condition milk for baby stabilizing agent)
The liquid condition milk for baby formula of this Comparative Examples is (in one ton of product):
The production technology of the liquid condition milk for baby of this Comparative Examples 1 is with embodiment 1, the liquid condition milk for baby product feature of Comparative Examples 1 is: fat content is about 3.1%, protein content is about 2.3% (lactalbumin and caseic ratio are 3: 2), the product viscosity is about 5.73~7.21 centipoises (No. 0 rotor of Brookfield LVDV-III type, 30rpm, 25 ℃ of room temperatures), the pH value is about 6.7.This product smooth mouth feel when drinking is smooth and easy, and local flavor is near breast milk and discharge good.
Comparative Examples 2
The liquid condition milk for baby formula of the present embodiment is (in one ton of product):
Wherein, stabilizing agent used is comprised of carragheen, guar gum, locust bean gum, monoglyceride, and weight ratio is 0.2: 2: 0.5: 2.Each material performance index used meets the correlated quality standard-required.
According to obtaining the liquid condition milk for baby product of the present embodiment after above-mentioned production technology production and can.Product after can dispatch from the factory after heat insulation experiment is qualified.
The liquid condition milk for baby product feature of the present embodiment is: fat content is about 3.1%, and protein content is about 2.3% (lactalbumin and caseic ratio are 3: 2), and the product viscosity is about 15~30 centipoises.No. 0 rotor of Brookfield LVDV-III type, 30rpm, 25 ℃ of room temperatures), the pH value is about 6.7.This product mouthfeel when drinking is partially thick, and local flavor is near breast milk, but discharges bad.
Product is fed test experiments
Select 300 routine babies of in October, 2009~2010 year birth in September to test, wherein boy baby's 150 examples, girl baby's 150 examples.These babies are mature the first tire, and BWt is at 2.9~3.2kg, and height is at 49~51cm.In 0~30 day without any disease.The baby group that monthly age is identical, object is fed in the conduct of height, body weight, head circumference no difference of science of statistics.Father and mother are supporter or volunteers of this plan.Two groups of infants' educational level of parents and family economic status aspect no difference of science of statistics.The baby of screening does not belong to lactose intolerance, lactoprotein inadaptation crowd.
According to experimental design, be divided into boy baby's group and girl baby's group, each group is divided into again breast-feeding group, infant formula liquid milk group (the liquid breast formula of use is embodiment 1), infant formula nursing group (babies ' formula milk powder of use is the commercially available baby milk powder of Erie).
Breast-feeding to 3 month, grouping experiment is measured the index of the reflection infants growth and developments such as body weight, height, upper-arm circumference.The feeding volume of suggestion sees Table 1.The formula powder feeding volume is converted to the volume number of immediate status.
The feeding volume of table 1 suggestion
| Average weight | Feeding volume | ||
| Monthly age | kg | ml | 24h feeds number of |
| 2 months | 4.7 | 170 | 5 |
| 4 months | 6.5 | 230 | 5 |
| 6 months | 7.5 | 250 | 4 |
Different feeding mode and physical growth of infants the results are shown in Table 2
Table 2 feeding patterns and physical growth of infants be x ± s as a result
As seen from Table 2,3 months to 6 months, the difference between formulated infant milk group, infant formula group and breast-feeding group diminished.That is to say, along with the increase at baby's monthly age, the different feeding mode reduces the difference of physical growth of infants.In addition, the physical growth of infants result that can find out the formulated infant milk group is better than the infant formula group.Formulated infant milk is watered the difference of ratio when having overcome the artificial feeding formula powder, guaranteed the reasonable content of nutrition component; The inhomogeneities that reconstitutes, the shortcoming that particle is thicker have also been avoided.Studies show that formulated infant milk is balanced in nutrition, delicate mouthfeel, be easy to absorb, can satisfy baby's normal growth and grow.
The product stability test experiments
Take embodiment 1~4 and Comparative Examples 1,2 liquid condition milk for baby product as specimen is placed at normal temperature (18~25 ℃ of left and right), standing observation under 37 ℃ of baking ovens (36~38 ℃) condition, by fat floating amount and precipitation capacity to product, the stability of product is analyzed.
(1) centrifugal breaking test detection method: embodiment 1~4 and Comparative Examples 1,2 product are used EBA21 type centrifuge, and the 10ml centrifuge tube carries out 4000 and turns, the centrefuge experiment of 30 minutes.
If centrifugal product layering or centrifuge tube precipitation capacity occur greater than 2ml, description effect is undesirable, and stability is bad; Otherwise preliminary identification has good stability, and waits until long-time stability and observes.
The method of (2) granularmetric analysis method is: use MASTERSIZER 2000 laser diffraction granularity analyzers to analyze embodiment 1~4 and Comparative Examples 1,2 product, select that the particle refractive index is 1.35, granule absorbance is that 0 program is measured.
If in milk, bulky grain is many, description effect is undesirable, and stability is bad; Otherwise preliminary identification has good stability, and waits until long-time stability and observes.
(3) the visual observations method is: the product sterile filling in 250ml Germany SCHOTT DURAN glass in trial jar, standing placement.See through the whole and part state in vial visual observations product under static condition, mainly pay attention to the following aspects of product: whether structural state has layering; Whether liquid level has the bleed phenomenon; Whether gel and caking phenomenon are arranged in product.
(4) the fat floating detection method is: the product sterile filling in the colorimetric cylinder of 100ml, standing placement.The ruler that is 0.5mm across vial wall precision under static condition is measured the white fat deposit thickness in milk surface, and during reading, sight is looked squarely.
Concrete experimental result is as follows: the centrifugal product in centrifugal breaking test detection method (centrifugal sample is to produce the fresh sample that obtains in the week) experimental result is recorded in following table 3:
The centrifugal breaking test of table 3 detects stability result
The result of using MASTERSIZER 2000 laser diffraction granularity analyzers that product feed liquid (analytic sample is to produce the fresh sample that obtains in the week) is analyzed sees also Fig. 1~Fig. 6, wherein, Fig. 1~Fig. 4 is the particle size distribution figure that utilizes the laser diffraction granularity analyzer that particle diameter in the liquid condition milk for baby milk of embodiment 1~embodiment 4 is analyzed; The particle size distribution figure that Fig. 5,6 analyzes for particle diameter in Comparative Examples 1,2 liquid condition milk for baby milk.
Observed result such as following table 4 under the normal temperature that long-time stability is observed:
Table 4 long-time stability observed result (18~25 ℃, 240 days)
37 ℃ of lower observed results that long-time stability is observed such as following table 5
Table 5 long-time stability observed result (36~38 ℃, 60 days):
Investigating result from above stability experiment can find out: utilize the prepared liquid condition milk for baby of stabilizing agent of the present invention (embodiment 1~embodiment 4) product structural state after the normal temperature preservation was placed 2 months in 8 months and 37 ℃ even, only have a small amount of fat floating phenomenon and slight precipitation, compare with Comparative Examples 2 with commercially available similar baby's liquid dairy product (Comparative Examples 1), liquid condition milk for baby product stability of the present invention is better, and shelf life is longer.
By obtaining stabiliser compositions of the present invention with above-mentioned composition proportion, it can make the stability of liquid lacteal product obtain beyond thought improvement, thereby the holding time is longer, and particularly for the liquid condition milk for baby of complicated component, stabiliser compositions of the present invention is especially applicable.
Claims (4)
1. stabiliser compositions, said composition is comprised of carragheen, guar gum, locust bean gum and monoglyceride, and wherein, the weight ratio of described carragheen, guar gum, locust bean gum, monoglyceride is 0.04~0.13:0.2~1:1~2:0.5~1.5.
2. stabiliser compositions according to claim 1, wherein, described carragheen is κ type carragheen.
3. the described stabiliser compositions of claim 1 or 2 is as the application of stabilizing agent in the liquid lacteal product of baby's use in 6 months of coming into being.
4. application according to claim 3, wherein, described stabiliser compositions is that 0.04 ‰~0.13 ‰ amount of the gross weight take the amount of carragheen wherein as the described nascent liquid lacteal product that uses to 6 months babies is added in described liquid lacteal product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103651138A CN102406102B (en) | 2011-11-17 | 2011-11-17 | Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103651138A CN102406102B (en) | 2011-11-17 | 2011-11-17 | Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102406102A CN102406102A (en) | 2012-04-11 |
| CN102406102B true CN102406102B (en) | 2013-06-05 |
Family
ID=45908669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103651138A Active CN102406102B (en) | 2011-11-17 | 2011-11-17 | Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102406102B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2895000A2 (en) * | 2012-09-12 | 2015-07-22 | Nestec S.A. | Thickened dairy or dairy-like products and methods for producing same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101253889A (en) * | 2007-09-06 | 2008-09-03 | 丹尼斯克(中国)有限公司 | A stabilizer composition for dairy products and its application |
| CN101233873B (en) * | 2008-02-02 | 2010-12-01 | 内蒙古蒙牛乳业(集团)股份有限公司 | Liquid state milk suitable for baby from newborn to six months old |
| CN101720876B (en) * | 2008-10-28 | 2012-05-30 | 内蒙古伊利实业集团股份有限公司 | Stabilizer composition, application thereof and milk beverage containing same |
| CN101720874B (en) * | 2008-10-28 | 2012-03-21 | 内蒙古伊利实业集团股份有限公司 | Stabilizer composition, application thereof and liquid diary product containing same |
-
2011
- 2011-11-17 CN CN2011103651138A patent/CN102406102B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102406102A (en) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101233873B (en) | Liquid state milk suitable for baby from newborn to six months old | |
| CN101218940B (en) | DHA added liquid condition milk for baby | |
| CN102524421B (en) | Novel acid-base balance infant formula milk powder and preparation method thereof | |
| CN103110117A (en) | Compound protein powder and preparation method thereof | |
| CN102422900A (en) | Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof | |
| CN101427783A (en) | Liquid milk for pregnant and ylying-in woman with additive plant fats and method of producing the same | |
| CN101313715A (en) | Liquid milk with additive vitamin suitable for baby of 12 to 36 months ages | |
| CN102028034B (en) | Acid anti-oxidation liquid dairy product and preparation method thereof | |
| CN105532919B (en) | A kind of full nutrition children prescription emulsifiable powder and preparation method thereof | |
| CN103070242A (en) | Formula goat milk powder for pregnant women and preparation method of formula goat milk powder | |
| CN101427797A (en) | Liquid milk with additive arachidonic acid suitable for baby of 0 to 6 months old | |
| CN101176487B (en) | Peanut nutrition milk and preparation method thereof | |
| CN101427792A (en) | Liquid milk with additive arachidonic acid (AA) suitable for baby of 6 to 12 months old | |
| CN105613972A (en) | Vitamin B2 enriched egg production method | |
| CN101313700B (en) | Liquid milk for baby of 6 to 12 months ages and preparation method of injection type direct disinfection | |
| CN101218942B (en) | Serum albumin added liquid condition milk for baby | |
| CN101218941B (en) | Mineral matter element added liquid condition milk for baby | |
| CN102406102B (en) | Stabilizing agent composition and its application in liquid state milk for neonates to 6-month babies | |
| CN103053990A (en) | Malt cream powder spice and preparation method thereof | |
| CN102524401B (en) | Nutrient raw material composition, nutrient and preparation method | |
| CN101317596B (en) | Liquid milk for baby of 12 to 36 months age and method for using on-line addition technique thereof | |
| CN112841310A (en) | Newborn formula liquid milk and preparation method thereof | |
| CN101313702A (en) | Liquid milk for baby of 6 to 12 months ages and preparation method with ejection type direct disinfection | |
| CN101233875A (en) | Liquid state milk suitable for baby from 6 to 12 months old | |
| CN101755922A (en) | Acid liquid milk product added with salt algae powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |